Genprex, inc. (GNPX)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Sep'16
Revenues

-

-

-

-

-

-

-

-

0

0

0

0

0

0

Cost and expenses:
Depreciation

5

3

3

3

2

2

1

1

0

1

0

0

0

0

Research and development

1,477

489

467

502

508

317

489

112

51

61

55

104

68

89

General and administrative

4,092

1,934

1,909

3,198

1,659

3,124

1,705

5,921

634

602

658

1,075

682

629

Total costs and expenses

5,576

2,427

2,380

3,703

2,170

3,443

2,197

6,036

686

664

715

1,181

751

719

Operating loss

-5,576

-2,427

-2,380

-3,703

-2,170

-3,443

-2,197

-6,036

-686

-664

-715

-1,181

-751

-719

Interest income

10

2

5

8

11

12

11

5

0

0

0

0

0

0

Interest expense

-

-

-

-

-

0

0

30

7

1

0

0

0

-

Other expense

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Income tax expense

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net loss

-5,566

-2,424

-2,375

-3,695

-2,158

-3,431

-2,186

-6,061

-694

-666

-715

-1,181

-751

-719

Net loss per share—basic and diluted (in dollars per share)

-0.20

-0.13

-0.15

-0.24

-0.14

-0.24

-0.15

-0.45

-0.06

-0.06

-0.06

-0.10

-0.07

-2.25

Weighted average number of common shares— basic and diluted (in shares)

27,952

17,317

15,831

15,622

15,335

15,162

14,675

13,507

11,738

11,504

11,634

11,480

11,380

320